10 Mar 2015 Myriad RBM Launches New Immunoassay Services Based on the Ultrasensitive Simoa™ Platform March 10, 2015 huckster Press Media Contact: Ron Rogers (801) 584-3065 [email protected] Investor Contact: Scott Gleason (801) 584-1143 [email protected] ...Read More
20 Jan 2015 Myriad RBM Joins Institut Pasteur in the Global Fight against Tuberculosis January 20, 2015 huckster Press Media Contact: Ron Rogers (801) 584-3065 [email protected] Investor Contact: Scott Gleason (801) 584-1143 [email protected] ...Read More
20 Mar 2014 Institut Pasteur and Myriad RBM Publish Initial Results from Landmark Study of Immune Response March 20, 2014 huckster Press Media Contact: Ron Rogers (801) 584-3065 [email protected] Investor Contact: Scott Gleason (801) 584-1143 [email protected] Institut Past...Read More
19 Jun 2013 DaVita Labs and Myriad RBM Announce Biomarker Research Collaboration June 19, 2013 huckster Press DaVita Contact: Bianca Violante (303) 876-6614 [email protected] Investor Contact: Jim Gustafson (310) 536-2585 [email protected]Read More
10 Dec 2012 Myriad Announces Diabetes Collaboration with Sanofi – Press Release December 10, 2012 huckster Press Myriad Contacts Investor Relations: Jim Evans, Chief Financial Officer (801) 584-1143 [email protected] Myriad RBM: Chris Martin, Director o...Read More
25 Jul 2012 Bio-Rad and Myriad RBM Partner to Commercialize Multiplex Biomarker Kits for Life Science Research July 25, 2012 Desiree Klingler-Gaston Press HERCULES, CA and AUSTIN, TX July 24, 2012 - Bio Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life scie...Read More
9 May 2012 Myriad RBM Announces the Launch of OncologyMAP® v. 2.0 May 9, 2012 huckster Press New panel expands Myriad RBM's cancer-related drug and companion diagnostic discovery service offering. Salt Lake City, UT (PRWEB) May 09, 2012...Read More